Navigation Links
Genomic Health to Announce Second Quarter 2012 Financial Results and Host Conference Call on Wednesday, August 8, 2012
Date:8/1/2012

t cancer test, has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in invasive breast cancer and has been shown to predict the likelihood of recurrence in ductal carcinoma in situ (DCIS).  In addition to this widely adopted test, Genomic Health provides the Oncotype DX colon cancer test, the first multi-gene expression test developed for the assessment of risk of recurrence in patients with stage II and stage III disease.  As of March 31, 2012, more than 10,000 physicians in over 65 countries had ordered more than 275,000 Oncotype DX tests.  Genomic Health has a robust pipeline focused on developing tests to optimize the treatment of prostate and renal cell cancers, as well as additional treatment decisions in breast and colon cancers.  The company is based in Redwood City, California with European headquarters in Geneva, Switzerland.  For more information, please visit, www.GenomicHealth.com. To learn more about Oncotype DX tests, visit: www.OncotypeDX.com and www.mybreastcancertreatment.org.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the attributes and focus of the company's product pipeline, the ability of the company to develop additional tests in the future, and the ability of any potential tests the company may develop to optimize cancer treatment. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, and reported results should not be consider
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Elsevier Launches New Open Access Journal: Applied and Translational Genomics
2. Life Technologies Acquires Pinpoint Genomics and CLIA-Approved Lung Cancer Test
3. Life Technologies Signs Collaborative Agreement with Structural Genomics Consortium to Develop First Antibody Master Set for Epigenetic Studies
4. Gentris Corporation Launches New Pharmacogenomics Services
5. Rubicon Genomics Launches ThruPLEX™ Family of Sample Preparation Products for Next Generation Sequencing Applications
6. Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Teli
7. Genomic Health to Announce First Quarter 2012 Financial Results and Host Conference Call on Wednesday, May 2, 2012
8. Empire Genomics Chooses Funakoshi as Japan Distributor
9. Save Up To 25% on International Biotech and Healthcare, and Pharmaceutical Conferences by Registering Through GII
10. Independa, IDEAL LIFE to Provide Plug-and-Play Health Monitoring for Independent Elderly and Their Caregivers
11. GHX WebConnect Fuels Healthcare Efficiency at 2012 Olympics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 29, 2015 Research and ... of the "Surgical/Operating Microscopes Market by Application ... report to their offering.      ... market is poised to reach $806.6 million by ... CAGR of 12.3% from 2015 to 2020. , ...
(Date:5/29/2015)... 29, 2015  Eli Lilly and Company (NYSE: ... announced that they have entered into a clinical trial ... AstraZeneca,s investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736, in combination ... antiangiogenic cancer medicine. The planned study will assess the ... tumors. The Phase I study is expected ...
(Date:5/28/2015)... Ind. , May 28, 2015 Zimmer ... that it has finalized agreements with buyers to divest ... Zimmer® Unicompartmental High-Flex Knee System assets, Biomet Discovery® Elbow ... agreements are in furtherance of Zimmer,s pending acquisition of ... Zimmer continues to work constructively with the Bureau ...
Breaking Medicine Technology:Surgical/Operating Microscopes Market by Application & End User - Global Forecast to 2020 for the $806 Million Industry 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 3Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 4Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 6Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 7Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 8Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 9Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 10Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 11Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 12Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 13Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 14Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 2Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 3Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 4Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 5Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 6
... Inc. (Nasdaq: NUVA ), a medical device company ... for the spine, announced today that Kevin O,Boyle, Chief ... the Oppenheimer 20th Annual Healthcare Conference at The Waldorf ... November 3, 2009. , A live webcast of the ...
... your stomach, relieve your wallet , YONKERS, N.Y., Oct. ... us may suffer from occasional heartburn, a new Best Buy Drugs ... don,t need an expensive drug like Nexium, the "purple pill," for ... to identify "Best Buys" based on safety, effectiveness, and price for ...
Cached Medicine Technology:NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference 2NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference 3Consumer Reports Health: Americans With Heartburn Paying Too Much Green For Nexium's 'Purple Pill' 2Consumer Reports Health: Americans With Heartburn Paying Too Much Green For Nexium's 'Purple Pill' 3
(Date:5/30/2015)... Alexandria, VA (PRWEB) May 30, 2015 ... Research Foundation interviewed Dr. Charles Simone and Dr. ... Medicine, during its ‘Meet the Mesothelioma Experts’ series. ... interviews focusing on mesothelioma centers of excellence. Drs. ... Foundation’s executive director, Mary Hesdorffer, with whom they ...
(Date:5/30/2015)... May 30, 2015 Responding to surging ... travelers who experienced OGAWA products while abroad, OGAWA-engineered massage ... , A leader in the Asian health and ... designer, researcher, developer and manufacturer of health and wellness ... craftsmanship of their products, health enthusiasts in Asia and ...
(Date:5/30/2015)... Cyclist Barry Haarde will commence ... World 2015: Piles of Miles” near San Francisco, ... hemophilia and encourage individuals to support needy hemophilic ... One Life supports nearly 1,200 impoverished children and ... direct sponsorships, scholarships and micro-enterprise grants. Hemophilia is ...
(Date:5/30/2015)... The iconic American actor, and host of “In ... segment on Medical Malpractice. This segment of “In America” ... health care field. , According to the Bureau of ... were filed, roughly only 20% of them made it ... while the remaining 30% were tossed out. (Source: ...
(Date:5/30/2015)... Venus Viva has proven to work ... deep wrinkles, stretch marks, pigmentation irregularities, and uneven texture ... Dr. F. Victor Rueckl of Lakes Dermatology in Las ... Las Vegas. This body image solution combines NanoFractional Radio ... delivers proven results through a skin heating process that ...
Breaking Medicine News(10 mins):Health News:Interview with Mesothelioma Experts, Drs. Simone and Alley Now Available on Demand 2Health News:Award-winning OGAWA Massage Chairs Finally Available for purchase in North America. 2Health News:Award-winning OGAWA Massage Chairs Finally Available for purchase in North America. 3Health News:Barry Haarde Cycles 4,000 Miles Across the USA for Hemophilia 2Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 2Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 3
... study shows that people with a low potassium intake are ... Previous research has suggested that reduced quantities of potassium in ... focus on potassium is, perhaps, a new one - for ... intake low to avoid stroke. But sodium and potassium chemistry ...
... heart improves function in patients with advanced heart failure. Researchers ... failure, the heart enlarges and is unable to effectively pump ... too. Heart failure is a progressive condition, with no cure ... with medication. ,However, a new cardiac support device ...
... eases hand spasticity among stroke survivors. Spasticity in the limbs ... much disability,// because it interferes with activities like getting dressed ... a substance that relieves muscle tightness - may help with ... botulinum toxin (also known as botox) in stroke, a group ...
... new study, the the functionality of lungs can be well ... our early days. Scientists have long known a test called ... an effective measure of lung function and predictor of morbidity ... investigators have speculated factors like exposure to tobacco smoke during ...
... works better than relaxation in lessening the symptoms of ... of 120 patients diagnosed with fibromyalgia, a painful muscular ... the patients were initiated to routine sessions of graded ... ,After three months, more of those in the exercise ...
... research it is found that an enzyme that rectifies ... reducing a person's susceptibility to diseases such as hemophilia, ... Wales and the University of Edinburgh in Scotland have ... mutations that can lead to diseases. ,Different combinations ...
Cached Medicine News:
... Since 1991 Intersurgical Incorporated ... filters, heat and moisture ... therapy products, hand-held nebulizers ... of accessories and connectors ...
The Pall High Performance HME is a high efficiency heat and moisture exchanger, indicated to protect patients against the potential risks of ventilation with dry and cold gases....
Passive heat and moisture exchangers for respiratory applications....
Ballard trach care HMES and filters, tv 1500, HME with built-in flex tube...
Medicine Products: